228 related articles for article (PubMed ID: 34358075)
21. Protective effect of pioglitazone on ovarian ischemia reperfusion injury of female rats via modulation of peroxisome proliferator activated receptor gamma and heme-oxygenase 1.
Refaie MMM; El-Hussieny M
Int Immunopharmacol; 2018 Sep; 62():7-14. PubMed ID: 29966944
[TBL] [Abstract][Full Text] [Related]
22. The peroxisome proliferator-activated receptor gamma agonist pioglitazone improves nitric oxide availability, renin-angiotensin system and aberrant redox regulation in the kidney of pre-hypertensive rats.
Kvandova M; Barancik M; Balis P; Puzserova A; Majzunova M; Dovinova I
J Physiol Pharmacol; 2018 Apr; 69(2):. PubMed ID: 29980143
[TBL] [Abstract][Full Text] [Related]
23. Apoptotic signaling pathways in uteri of rats with endometrial hyperplasia induced by ovariectomy combined with estrogen.
He F; Zhang W; Zhang H
Gynecol Obstet Invest; 2013; 76(1):51-6. PubMed ID: 23751213
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of vascular angiotensin-converting enzyme by telmisartan via the peroxisome proliferator-activated receptor gamma agonistic property in rats.
Takai S; Jin D; Kimura M; Kirimura K; Sakonjo H; Tanaka K; Miyazaki M
Hypertens Res; 2007 Dec; 30(12):1231-7. PubMed ID: 18344629
[TBL] [Abstract][Full Text] [Related]
25. Peroxisome proliferator-activated receptor gamma agonists promote TRAIL-induced apoptosis by reducing survivin levels via cyclin D3 repression and cell cycle arrest.
Lu M; Kwan T; Yu C; Chen F; Freedman B; Schafer JM; Lee EJ; Jameson JL; Jordan VC; Cryns VL
J Biol Chem; 2005 Feb; 280(8):6742-51. PubMed ID: 15569667
[TBL] [Abstract][Full Text] [Related]
26. Chrysin attenuates estradiol-induced endometrial hyperplasia in rats via enhancing PPARα activity.
Eid BG
Environ Sci Pollut Res Int; 2022 Aug; 29(36):54273-54281. PubMed ID: 35301625
[TBL] [Abstract][Full Text] [Related]
27. Telmisartan protects against diabetic vascular complications in a mouse model of obesity and type 2 diabetes, partially through peroxisome proliferator activated receptor-γ-dependent activity.
Toyama K; Nakamura T; Kataoka K; Yasuda O; Fukuda M; Tokutomi Y; Dong YF; Ogawa H; Kim-Mitsuyama S
Biochem Biophys Res Commun; 2011 Jul; 410(3):508-13. PubMed ID: 21679694
[TBL] [Abstract][Full Text] [Related]
28. Activation of the cell membrane angiotensin AT2 receptors in human leiomyosarcoma cells induces differentiation and apoptosis by a PPARγ - dependent mechanism.
LÜtzen U; Zhao Y; Lucht K; Zuhayra M; Hedderich J; Cascorbi I; Culman J
Neoplasma; 2017; 64(3):395-405. PubMed ID: 28253719
[TBL] [Abstract][Full Text] [Related]
29. Immunohistochemical reaction of the glandular epithelium in endometrial hyperplasia compared to endometrial carcinoma.
Stoenescu VE; Niculescu M; Novac L; Manolea MM; Tomescu PI; Dijmărescu AL; Novac MB; Tudorache Ş; Iliescu DG
Rom J Morphol Embryol; 2017; 58(3):791-800. PubMed ID: 29250656
[TBL] [Abstract][Full Text] [Related]
30. Irbesartan prevents metabolic syndrome in rats via activation of peroxisome proliferator-activated receptor γ.
Takai S; Jin D; Miyazaki M
J Pharmacol Sci; 2011; 116(3):309-15. PubMed ID: 21691037
[TBL] [Abstract][Full Text] [Related]
31. Prevention of hypertension by irbesartan in Dahl S rats relates to central angiotensin II type 1 receptor blockade.
Leenen FH; Yuan B
Hypertension; 2001 Mar; 37(3):981-4. PubMed ID: 11244027
[TBL] [Abstract][Full Text] [Related]
32. Peroxisome proliferator-activated receptor gamma and growth inhibition by its ligands in uterine endometrial carcinoma.
Ota K; Ito K; Suzuki T; Saito S; Tamura M; Hayashi S; Okamura K; Sasano H; Yaegashi N
Clin Cancer Res; 2006 Jul; 12(14 Pt 1):4200-8. PubMed ID: 16857792
[TBL] [Abstract][Full Text] [Related]
33. PPARgamma-activating angiotensin type-1 receptor blockers induce adiponectin.
Clasen R; Schupp M; Foryst-Ludwig A; Sprang C; Clemenz M; Krikov M; Thöne-Reineke C; Unger T; Kintscher U
Hypertension; 2005 Jul; 46(1):137-43. PubMed ID: 15939809
[TBL] [Abstract][Full Text] [Related]
34. Effect of telmisartan on nitric oxide--asymmetrical dimethylarginine system: role of angiotensin II type 1 receptor gamma and peroxisome proliferator activated receptor gamma signaling during endothelial aging.
Scalera F; Martens-Lobenhoffer J; Bukowska A; Lendeckel U; Täger M; Bode-Böger SM
Hypertension; 2008 Mar; 51(3):696-703. PubMed ID: 18250362
[TBL] [Abstract][Full Text] [Related]
35. Angiotensin receptor-neprilysin inhibitior (thiorphan/irbesartan) decreased ischemia-reperfusion induced ventricular arrhythmias in rat; in vivo study.
Abdulsalam TM; Hasanin AH; Mohamed RH; El Sayed Badawy A
Eur J Pharmacol; 2020 Sep; 882():173295. PubMed ID: 32593664
[TBL] [Abstract][Full Text] [Related]
36. Telmisartan exerts renoprotective actions via peroxisome proliferator-activated receptor-γ/hepatocyte growth factor pathway independent of angiotensin II type 1 receptor blockade.
Kusunoki H; Taniyama Y; Azuma J; Iekushi K; Sanada F; Otsu R; Iwabayashi M; Okayama K; Rakugi H; Morishita R
Hypertension; 2012 Feb; 59(2):308-16. PubMed ID: 22252391
[TBL] [Abstract][Full Text] [Related]
37. Influence of COX-2 inhibition by rofecoxib on serum and tumor progastrin and gastrin levels and expression of PPARgamma and apoptosis-related proteins in gastric cancer patients.
Konturek PC; Konturek SJ; Bielanski W; Kania J; Zuchowicz M; Hartwich A; Rehfeld JF; Hahn EG
Dig Dis Sci; 2003 Oct; 48(10):2005-17. PubMed ID: 14627349
[TBL] [Abstract][Full Text] [Related]
38. Effect of irbesartan on the antioxidant defence system and nitric oxide release in diabetic rat kidney.
Anjaneyulu M; Chopra K
Am J Nephrol; 2004; 24(5):488-96. PubMed ID: 15353911
[TBL] [Abstract][Full Text] [Related]
39. Sevoflurane Protects against Intestinal Ischemia-Reperfusion Injury by Activating Peroxisome Proliferator-Activated Receptor Gamma/Nuclear Factor-κB Pathway in Rats.
Liu C; Ding R; Huang W; Miao L; Li J; Li Y
Pharmacology; 2020; 105(3-4):231-242. PubMed ID: 31655824
[TBL] [Abstract][Full Text] [Related]
40. An estrogen-induced endometrial hyperplasia mouse model recapitulating human disease progression and genetic aberrations.
Yang CH; Almomen A; Wee YS; Jarboe EA; Peterson CM; Janát-Amsbury MM
Cancer Med; 2015 Jul; 4(7):1039-50. PubMed ID: 25809780
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
